Lauren Brunelli*
Over the past few decades, stem cell-based cardiac regeneration has emerged as a promising therapy for patients with heart failure, a condition that affects millions of people worldwide. Stem cells have the ability to differentiate into various types of cells, including heart cells, and can potentially be used to replace damaged or dead heart tissue. One of the challenges in using stem cells for cardiac regeneration is creating a suitable environment for their growth and differentiation. Traditional two-dimensional (2D) culture methods have limitations in mimicking the complex three-dimensional (3D) environment of the heart. This is where 3D organoid models come into play. Organoids are 3D structures that can be grown from stem cells, which can self-organize and differentiate into specific cell types, mimicking the structure and function of organs. In the context of cardiac regeneration, 3D organoids can be used to model heart tissue, providing a more accurate representation of the complex 3D architecture of the heart. Recent advances in 3D organoid models for stem cell-based cardiac regeneration have shown promising results. For example, researchers have been able to create 3D heart organoids from human induced pluripotent stem cells (iPSCs), which can be used for drug screening, disease modeling, and potentially for transplantation.
Partagez cet article